-
Several institutions have received grants to implement their ideas for engaging the community in cancer clinical trials.
-
IRBs in the United States and research ethics committees (RECs) in the developing world who review HIV vaccine trials must struggle with a number of tough ethical issues ensuring adequate, culturally sensitive informed consent, protecting privacy, determining the standard of treatment for participants who become infected with HIV during a trial.
-
An innovative program at M.D. Anderson Cancer Center in Houston, TX, provides continuous oversight of investigational new drug (IND) trials over the life of a trial, using a monitoring services office created expressly for that purpose.
-
In lean times, IRBs will have to become more disciplined. And part of their discipline will need to include collecting data about their own efficiency, outcomes, and cost-effectiveness, an expert says.
-
IRBs across the nation are bracing for budget cuts as states slice funding to higher education and the recession's impact is felt by IRBs and research institutions.
-
News: A man sustained lacerations to his right index finger and middle finger and was immediately taken to the emergency department (ED) of a local hospital, where a physician's assistant sutured the wound. The man returned to the hospital on three occasions, where hospital officials noted decreased extension in the man's long finger of his right hand.
-
News: Following an elective thyroidectomy, a woman was diagnosed with hypocalcemia. Although calcium was ordered, it was never administered to the woman, despite persistent symptoms of the calcium deficiency. The woman eventually went into cardiac arrest and sustained anoxic encephalopathy, becoming comatose.
-
The recent high-profile conviction of a hospital CEO involved in kickbacks and providing unnecessary care to homeless patients shows that risk managers always must be on alert for illegal activities that may be hidden behind the doors of an executive suite.
-
This is the second of a two-part series about the hidden risks and liabilities of medical helicopters. In last month's Healthcare Risk Management, we explored the risks and reviewed recent crashes. This month, we compile advice on lowering those risks and take a closer look at one hospital that has revamped its medical helicopter system after experiencing two crashes.
-
Don't believe anyone who tells you the health care industry is "recession-proof," says Thomas E. Getzen, PhD, professor of risk, insurance, and health management at the Fox School of Business at Temple University in Philadelphia. Getzen also is executive director of the International Health Economics Association.